The maker of a popular medicine for schizophrenia has notified doctors that it minimized potentially fatal safety risks and made misleading claims about the drug in promotional materials.

Janssen Pharmaceutic Products sent a two-page letter to the health care community this past week to clarify the risks of Risperdal, Carol Goodrich, a spokeswoman for the Johnson & Johnson subsidiary, said Saturday.

 


Comments


View Comments / Leave a Comment

This post currently has 0 comments.
You can read the comments or leave your own thoughts.


    Last reviewed: By John M. Grohol, Psy.D. on 27 Jul 2004
    Published on PsychCentral.com. All rights reserved.

APA Reference
Grohol, J. (2004). Drug Maker Acknowledges Misleading Claims. Psych Central. Retrieved on February 19, 2015, from http://psychcentral.com/blog/archives/2004/07/27/drug-maker-acknowledges-misleading-claims/

 

Recent Comments
  • Mozart: Wow, article describes Barrack Hussein Obama to a fault…….
  • Myself: My bpd daughter is now 25 and pregnant. For the first 2mths of pregnancy she appeared calm and considerate...
  • SarahB: I must say, I cannot remember reading a more offensive article on the subject of relationships with Cluster B...
  • creativelady: I found this article very helpful… Good ideas on how to be compassionate towards your self…...
  • taosword: Bring all blames to oneself. This is what I have learned as a Buddhist. Its looking deep into how ones...
Subscribe to Our Weekly Newsletter


Find a Therapist
Enter ZIP or postal code



Users Online: 15726
Join Us Now!